(Q37929614)

25 August 2017

1 reference

title

The chemistry and biology of syringolins, glidobactins and cepafungins (syrbactins). (English)

1 reference

25 August 2017

Daniel Krahn

1

1 reference

PubMed ID

21904761

25 August 2017

Christian Ottmann

series ordinal

2

1 reference

PubMed ID

21904761

25 August 2017

Markus Kaiser

series ordinal

3

1 reference

25 August 2017

9 September 2011

1 reference

25 August 2017

Natural Product Reports

1 reference

25 August 2017

28

1 reference

25 August 2017

11

1 reference

25 August 2017

1854-1867

1 reference

A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism

25 August 2017

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Identification of genes involved in the biosynthesis of the cytotoxic compound glidobactin from a soil bacterium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Improvement of glidobactin A production by Polyangium brachysporum

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Functional analysis of genes involved in the synthesis of syringolin A by Pseudomonas syringae pv. syringae B301 D-R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Biosynthesis of the proteasome inhibitor syringolin A: the ureido group joining two amino acids originates from bicarbonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

SylC catalyzes ureido-bond formation during biosynthesis of the proteasome inhibitor syringolin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

N-acylation during glidobactin biosynthesis by the tridomain nonribosomal peptide synthetase module GlbF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Total synthesis of syringolin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Total synthesis of syringolin A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Structure of 20S proteasome from yeast at 2.4 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Recognition and processing of ubiquitin-protein conjugates by the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

20S proteasome and its inhibitors: crystallographic knowledge for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Probing structural determinants distal to the site of hydrolysis that control substrate specificity of the 20S proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Mixing of peptides and electrophilic traps gives rise to potent, broad-spectrum proteasome inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

The core structure of TMC-95A is a promising lead for reversible proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Binding mode of TMC-95A analogues to eukaryotic 20S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

TMC-95A analogues with endocyclic biphenyl ether group as proteasome inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Proteasome inhibition by fellutamide B induces nerve growth factor synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Syringolin A selectively labels the 20 S proteasome in murine EL4 and wild-type and bortezomib-adapted leukaemic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Activity-based protein profiling: from enzyme chemistry to proteomic chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Syringolin reprograms wheat to undergo hypersensitive cell death in a compatible interaction with powdery mildew.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Pseudomonas syringae virulence factor syringolin A counteracts stomatal immunity by proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

The persisting challenge of selective and specific proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Proteasome inhibitors in cancer therapy: lessons from the first decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Syringolin A, a new plant elicitor from the phytopathogenic bacterium Pseudomonas syringae pv. syringae, inhibits the proliferation of neuroblastoma and ovarian cancer cells and induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Syrbactin class proteasome inhibitor-induced apoptosis and autophagy occurs in association with p53 accumulation and Akt/PKB activation in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Napsamycins, new Pseudomonas active antibiotics of the mureidomycin family from Streptomyces sp. HIL Y-82,11372.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1NP00048A

Isolation of cepafungins I, II and III from Pseudomonas species

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.43.783

Glidobactins D, E, F, G and H; minor components of the antitumor antibiotic glidobactin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.1906

Enhanced production of the minor components of glidobactins in Polyangium brachysporum.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.1358

Glidobactins A, B and C, new antitumor antibiotics. II. Structure elucidation.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.1338

Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. II. Structural elucidation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.42.667

Glidobactins A, B and C, new antitumor antibiotics. I. Production, isolation, chemical properties and biological activity.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.1331

Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. II. Isolation and structural elucidation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.42.512

Identifiers

DOI

10.1039/C1NP00048A

1 reference

25 August 2017

1 reference

PubMed ID

21904761